← FDA Drug Approvals (Drugs@FDA)
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2016-10-11
Drug application
- FDA Application #
ANDA203594- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
- Generic name
- Drospirenone
- Active ingredients
- DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- WATSON LABS INC
- First approval
- 2016-10-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown